{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T04:14:27Z","timestamp":1773807267734,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,11,24]],"date-time":"2011-11-24T00:00:00Z","timestamp":1322092800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Complement Altern Med"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1472-6882-11-116","type":"journal-article","created":{"date-parts":[[2011,11,24]],"date-time":"2011-11-24T19:35:46Z","timestamp":1322163346000},"source":"Crossref","is-referenced-by-count":24,"title":["Safety and effects of two mistletoe preparations on production of Interleukin-6 and other immune parameters - a placebo controlled clinical trial in healthy subjects"],"prefix":"10.1186","volume":"11","author":[{"given":"Roman","family":"Huber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holger","family":"L\u00fcdtke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Wieber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christiane","family":"Beckmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,11,24]]},"reference":[{"key":"474_CR1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1201\/9780203304716","volume-title":"Mistletoe. The Genus Viscum","author":"A B\u00fcssing","year":"2000","unstructured":"B\u00fcssing A: Biological and pharmacological properties of Viscum album L. Mistletoe. The Genus Viscum. Edited by: B\u00fcssing A. 2000, Amsterdam: Harwood Academic Publishers, 123-182."},{"issue":"15-16","key":"474_CR2","first-page":"233","volume":"133","author":"F van der Weg","year":"2003","unstructured":"van der Weg F, Streuli RA: Use of alternative medicine by patients with cancer in a rural area of Switzerland. Swiss Medical Weekly. 2003, 133 (15-16): 233-240.","journal-title":"Swiss Medical Weekly"},{"key":"474_CR3","doi-asserted-by":"crossref","unstructured":"Horneber MA, Bueschel G, Huber R, Linde K, Rostock M: Mistletoe therapy in oncology. Cochrane Database Systematic Review. 2008, CD003297-2","DOI":"10.1002\/14651858.CD003297.pub2"},{"issue":"3","key":"474_CR4","first-page":"128","volume":"51","author":"S Gabius","year":"1999","unstructured":"Gabius S, Gabius HJ: Immunomodulating mistletoe therapy by lectin standardization: a double-edged sword?. Versicherungsmedizin. 1999, 51 (3): 128-36.","journal-title":"Versicherungsmedizin"},{"issue":"8-9","key":"474_CR5","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1159\/000087116","volume":"28","author":"M Hallek","year":"2005","unstructured":"Hallek M: Interleukin-6-mediated cell growth in multiple myeloma - a role for Viscum album extracts?. Onkologie. 2005, 28 (8-9): 387-10.1159\/000087116.","journal-title":"Onkologie"},{"issue":"1","key":"474_CR6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1182\/blood.V91.1.3","volume":"91","author":"M Hallek","year":"1998","unstructured":"Hallek M, Bergsagel PL, Anderson KC: Multiple myeloma: increasing evidence for a multistep transformation process. Blood. 1998, 91 (1): 3-21.","journal-title":"Blood"},{"issue":"1A","key":"474_CR7","first-page":"223","volume":"27","author":"G Kelter","year":"2007","unstructured":"Kelter G, Schierholz JM, Fischer IU, Fiebig HH: Cytotoxic activity and absence of tumor growth stimulation of standardized mistletoe extracts in human tumor models in vitro. Anticancer Research. 2007, 27 (1A): 223-233.","journal-title":"Anticancer Research"},{"key":"474_CR8","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1100\/tsw.2010.30","volume":"10","author":"E Kovacs","year":"2010","unstructured":"Kovacs E: Investigation of the proliferation, apoptosis\/necrosis, and cell cycle phases in several human multiple myeloma cell lines. Comparison of Viscum album QuFrF extract with vincristine in an in vitro model. ScientificWorld Journal. 2010, 10: 311-220.","journal-title":"ScientificWorld Journal"},{"issue":"11","key":"474_CR9","first-page":"592","volume":"58","author":"E Kovacs","year":"2008","unstructured":"Kovacs E, Link S, Toffol-Schmidt U: Comparison of Viscum album QuFrF extract with vincristine in an in vitro model of human B cell lymphoma WSU-1. Arzneimittelforschung. 2008, 58 (11): 592-597.","journal-title":"Arzneimittelforschung"},{"issue":"3","key":"474_CR10","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1159\/000021330","volume":"7","author":"C Stumpf","year":"2000","unstructured":"Stumpf C, Rosenberger A, Rieger S, Tr\u00f6ger W, Schietzel M: Mistletoe extracts in the therapy of malignant, hematological and lymphatic diseases--a monocentric, retrospective analysis over 16 years. Forschende Komplement\u00e4rmedizin und Klassische Naturheilkunde. 2000, 7 (3): 139-146. 10.1159\/000021330.","journal-title":"Forschende Komplement\u00e4rmedizin und Klassische Naturheilkunde"},{"key":"474_CR11","volume-title":"Richtlinien f\u00fcr die Malignom-Therapie mit Iscucin-Viscum-Pr\u00e4paraten","author":"HH Vogel","year":"1980","unstructured":"Vogel HH: Richtlinien f\u00fcr die Malignom-Therapie mit Iscucin-Viscum-Pr\u00e4paraten. Edited by: WALA-Heilmittel GmbH. 1980"},{"issue":"53","key":"474_CR12","first-page":"29","volume":"1","author":"M Sommer","year":"2000","unstructured":"Sommer M, Soldner G: Die Mistel und ihre Wirtsb\u00e4ume. Der Merkurstab. 2000, 1 (53): 29-43.","journal-title":"Der Merkurstab"},{"key":"474_CR13","first-page":"48","volume":"52","author":"C G\u00e4rtner","year":"1999","unstructured":"G\u00e4rtner C: Therapie der Arthrosen gro\u00dfer Gelenke. Der Merkurstab. 1999, 52: 48-51.","journal-title":"Der Merkurstab"},{"key":"474_CR14","first-page":"467","volume":"6","author":"T Zuzak","year":"2004","unstructured":"Zuzak T, Rist L, Viviani A, Eggenschwiler J, Mol C, Riegert U, Meyer U: Das Mistelpr\u00e4parat Iscucin\u00ae - Herstellung, Analytik, Wirkung in vitro. Der Merkurstab. 2004, 6: 467-473.","journal-title":"Der Merkurstab"},{"key":"474_CR15","unstructured":"Investigator's Brochure Iscucin Populi, strength F, G, H and Viscum Mali e planta tota D3, D2 and 2%. 2007, WALA Heilmittel GmbH"},{"issue":"6","key":"474_CR16","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1089\/10755530260511847","volume":"8","author":"R Huber","year":"2002","unstructured":"Huber R, Klein R, Berg PA, L\u00fcdtke R, Werner M: Effects of a lectin- and a viscotoxin-rich mistletoe preparation on clinical and hematologic parameters: a placebo-controlled evaluation in healthy subjects. Journal of Alternative and Complementary Medicine. 2002, 8 (6): 857-866. 10.1089\/10755530260511847.","journal-title":"Journal of Alternative and Complementary Medicine"},{"issue":"Suppl 1","key":"474_CR17","first-page":"S57","volume":"8","author":"GM Stein","year":"1997","unstructured":"Stein GM, Stettin A, Schultze J, Berg PA: Induction of anti-mistletoe lectin antibodies in relation to different mistletoe extracts. Anticancer_Drugs. 1997, 8 (Suppl 1): S57-S59.","journal-title":"Anticancer_Drugs"},{"issue":"10","key":"474_CR18","first-page":"411","volume":"10","author":"R Huber","year":"2005","unstructured":"Huber R, Rostock M, Goedl R, L\u00fcdtke R, Urech K, Buck S, Klein R: Mistletoe treatment induces GM-CSF- and IL-5 production by PBMC and increases blood granulocyte- and eosinophil counts: a placebo controlled randomized study in healthy subjects. European Journal of Medical Research. 2005, 10 (10): 411-418.","journal-title":"European Journal of Medical Research"},{"key":"474_CR19","volume-title":"Labor und Diagnose","year":"2000","unstructured":"Thomas L, Editor: Labor und Diagnose. 2000, TH-Books Verlagsgesellschaft Frankfurt\/Main, 5","edition":"5"},{"issue":"18","key":"474_CR20","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1056\/NEJM199511023331802","volume":"333","author":"PJ Bosma","year":"1995","unstructured":"Bosma PJ, Chowdhury JR, Bakker C, Gantla S, de Boer A, Oostra BA, Lindhout D, Tytgat GN, Jansen PL, Oude Elferink RP: The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. New England Journal of Medicine. 1995, 333 (18): 1171-1175. 10.1056\/NEJM199511023331802.","journal-title":"New England Journal of Medicine"},{"issue":"Suppl","key":"474_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1159\/000080571","volume":"1","author":"M Rostock","year":"2004","unstructured":"Rostock M, Huber R: Randomized and double-blind studies - demands and reality as demonstrated by two examples of mistletoe research. Forschende Komplement\u00e4rmedizin und Klassische Naturheilkunde. 2004, 1 (Suppl): 18-22.","journal-title":"Forschende Komplement\u00e4rmedizin und Klassische Naturheilkunde"},{"issue":"4","key":"474_CR22","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1159\/000226249","volume":"16","author":"J Melzer","year":"2009","unstructured":"Melzer J, Iten F, Hostanska K, Saller R: Efficacy and safety of mistletoe preparations (Viscum album) for patients with cancer diseases. A systematic review. Forschende Komplement\u00e4rmedizin. 2009, 16 (4): 217-226.","journal-title":"Forschende Komplement\u00e4rmedizin"},{"issue":"3","key":"474_CR23","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1532\/IJH97.04107","volume":"80","author":"M Oancea","year":"2004","unstructured":"Oancea M, Mani A, Hussein MA, Almasan A: Apoptosis of multiple myeloma. Int J Hematol. 2004, 80 (3): 224-231. 10.1532\/IJH97.04107.","journal-title":"Int J Hematol"},{"key":"474_CR24","volume-title":"Untersuchungen zur Interaktion von Mistelantigenen mit dem Immunsystem","author":"G Stein","year":"1995","unstructured":"Stein G: Untersuchungen zur Interaktion von Mistelantigenen mit dem Immunsystem. 1995, Doctorate thesis University Tuebingen, Germany"},{"issue":"4","key":"474_CR25","first-page":"194","volume":"3","author":"G Stein","year":"1998","unstructured":"Stein G, Henn W, von Laue H, Berg P: Modulation of the cellular and humoral immune responses of tumor patients by mistletoe therapy. Eur J Med Res. 1998, 3 (4): 194-202.","journal-title":"Eur J Med Res"},{"key":"474_CR26","first-page":"485","volume-title":"Die Mistel in der Tumortherapie. Grundlagenforschung und Klinik","author":"G Kaiser","year":"2001","unstructured":"Kaiser G, B\u00fcschel M, Horneber M, Smetak M, Birkmann J, Braun W, Fischer S, v. Laue HB, Scheer R, Gallmaier WM: Studiendesign und erste Ergebnisse einer prospektiven placebokontrollierten, randomisierten Studie mit AbnobaViscum Mali 4. Die Mistel in der Tumortherapie. Grundlagenforschung und Klinik. Edited by: Scheer R, Bauer R, Becker H, Berg PA, Fintelmann V. 2001, Essen: KVC publisher, 485-505."},{"key":"474_CR27","first-page":"288","volume-title":"Die Mistel in der Onkologie","author":"GS Kienle","year":"2003","unstructured":"Kienle GS, Kiene H: Wirkungen der Mistelextrakte auf Zytokine. Die Mistel in der Onkologie. 2003, Stuttgart, New York Schattauer, 288-296."},{"key":"474_CR28","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1159\/000210332","volume":"4","author":"A Preisfeld","year":"1997","unstructured":"Preisfeld A: Influence of aqueous mistletoe preparations on humoral immune parameters with emphasis on the cytotoxicity of human complement in breast cancer patients. Forschende Komplement\u00e4rmedizin. 1997, 4: 224-228.","journal-title":"Forschende Komplement\u00e4rmedizin"},{"issue":"1","key":"474_CR29","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/00045391-199901000-00006","volume":"6","author":"M van Wely","year":"1999","unstructured":"van Wely M, Stoss M, Gorter RW: Toxicity of a standardized mistletoe extract in immunocompromised and healthy individuals. American Journal of Therapeutics. 1999, 6 (1): 37-43. 10.1097\/00045391-199901000-00006.","journal-title":"American Journal of Therapeutics"},{"key":"474_CR30","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/0167-5699(96)80606-2","volume":"17","author":"TR Mosman","year":"1996","unstructured":"Mosman TR, Sad S: The expanding universe of Tcell subsets: Th1, Th2 and more. Immunology Today. 1996, 17: 138-146. 10.1016\/0167-5699(96)80606-2.","journal-title":"Immunology Today"},{"issue":"1","key":"474_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1399-0039.2007.00869.x","volume":"70","author":"JI Ellyard","year":"2007","unstructured":"Ellyard JI, Simson L, Parish CR: Th2-mediated anti-tumour immunity: friend or foe?. Tissue Antigens. 2007, 70 (1): 1-11. 10.1111\/j.1399-0039.2007.00869.x.","journal-title":"Tissue Antigens"},{"issue":"7","key":"474_CR32","doi-asserted-by":"publisher","first-page":"4222","DOI":"10.4049\/jimmunol.178.7.4222","volume":"178","author":"L Simson","year":"2007","unstructured":"Simson L, Ellyard JI, Dent LA, Matthaei KI, Rothenberg ME, Foster PS, Smyth MJ, Parish CR: Regulation of carcinogenesis by IL-5 and CCL11: a potential role for eosinophils in tumor immune surveillance. Journal of Immunology. 2007, 178 (7): 4222-4229.","journal-title":"Journal of Immunology"},{"issue":"5","key":"474_CR33","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/sj.bjc.6600161","volume":"86","author":"A Cuschieri","year":"2002","unstructured":"Cuschieri A, Talbot IC, Weeden S, MRC Upper GI Cancer Working Party: Influence of pathological tumour variables on long-term survival in resectable gastric cancer. British Journal of Cancer. 2002, 86 (5): 674-679. 10.1038\/sj.bjc.6600161.","journal-title":"British Journal of Cancer"},{"key":"474_CR34","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2407-1-7","volume":"1","author":"ID Nagtegaal","year":"2001","unstructured":"Nagtegaal ID, Marijnen CA, Kranenbarg EK, Mulder-Stapel A, Hermans J, van de Velde CJ, van Krieken JH: Local and distant recurrences in rectal cancer patients are predicted by the nonspecific immune response; specific immune response has only a systemic effect - a histopathological and immunohistochemical study. BMC Cancer. 2001, 1: 7-10.1186\/1471-2407-1-7.","journal-title":"BMC Cancer"},{"issue":"1","key":"474_CR35","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/sj.bjc.6601463","volume":"90","author":"M Mabed","year":"2004","unstructured":"Mabed M, El-Helw L, Shamaa S: Phase II study of viscum fraxini-2 in patients with advanced hepatocellular carcinoma. British Journal of Cancer. 2004, 90 (1): 65-69. 10.1038\/sj.bjc.6601463.","journal-title":"British Journal of Cancer"}],"container-title":["BMC Complementary and Alternative Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1472-6882-11-116\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6882-11-116.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6882-11-116","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6882-11-116.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,28]],"date-time":"2020-06-28T00:23:13Z","timestamp":1593303793000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/1472-6882-11-116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,24]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["474"],"URL":"https:\/\/doi.org\/10.1186\/1472-6882-11-116","relation":{},"ISSN":["1472-6882"],"issn-type":[{"value":"1472-6882","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,24]]},"article-number":"116"}}